Cargando…

Correction: Construction and validation of a prognostic model of RNA binding proteins in clear cell renal carcinoma

Detalles Bibliográficos
Autores principales:	Han, Wenkai, Fan, Bohao, Huang, Yongsheng, Wang, Xiongbao, Zhang, Zhao, Gu, Gangli, Liu, Zhao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9288062/ https://www.ncbi.nlm.nih.gov/pubmed/35840946 http://dx.doi.org/10.1186/s12882-022-02867-8

Ejemplares similares

Construction and validation of a prognostic model of RNA binding proteins in clear cell renal carcinoma
por: Han, Wenkai, et al.
Publicado: (2022)

Publisher Correction: Renal capsular invasion is a prognostic biomarker in localized clear cell renal cell carcinoma
por: Ha, U-Syn, et al.
Publicado: (2018)

Correction to: RNA-binding protein SORBS2 suppresses clear cell renal cell carcinoma metastasis by enhancing MTUS1 mRNA stability
por: Lv, Qi, et al.
Publicado: (2021)

Construction and Validation of Protein Expression-related Prognostic Models in Clear Cell Renal Cell Carcinoma
por: Ma, Xuzhan, et al.
Publicado: (2023)

Author Correction: Integrating multi-platform genomic datasets for kidney renal clear cell carcinoma subtyping using stacked denoising autoencoders
por: Gu, Tongjun, et al.
Publicado: (2019)

Correction to: Prognostic impact of immune gene expression signature and tumor infiltrating immune cells in localized clear cell renal cell carcinoma
por: Ghatalia, Pooja, et al.
Publicado: (2019)

Correction: Serum soluble B7-H4 is a prognostic marker for patients with non-metastatic clear cell renal cell carcinoma
Publicado: (2018)

Establishment and Validation of a Prognostic Risk Model for Autophagy-Related Genes in Clear Cell Renal Cell Carcinoma
por: Han, Wenkai, et al.
Publicado: (2020)

Construction and validation of a prognostic model for kidney renal clear cell carcinoma based on podocyte‐associated genes
por: Chen, Can, et al.
Publicado: (2022)

Correction: Overexpression of Wip1 Is Associated with Biologic Behavior in Human Clear Cell Renal Cell Carcinoma
Publicado: (2015)

Construction and validation of an m6A RNA methylation regulator prognostic model for early-stage clear cell renal cell carcinoma
por: Wang, Zhan, et al.
Publicado: (2022)

Correction: MicroRNA-30a-5p(me): a novel diagnostic and prognostic biomarker for clear cell renal cell carcinoma in tissue and urine samples
por: Outeiro-Pinho, Gonçalo, et al.
Publicado: (2022)

Correction to: PIM1 mediates epithelial-mesenchymal transition by targeting Smads and c-Myc in the nucleus and potentiates clear-cell renal-cell carcinoma oncogenesis
por: Zhao, Bin, et al.
Publicado: (2021)

Construction and Validation of an Autophagy-Related Prognostic Risk Signature for Survival Predicting in Clear Cell Renal Cell Carcinoma Patients
por: Yang, Huiying, et al.
Publicado: (2020)

Systematic Construction and Validation of a Novel Macrophage Differentiation–Associated Prognostic Model for Clear Cell Renal Cell Carcinoma
por: Liu, Chen, et al.
Publicado: (2022)

Construction and validation of a prognostic model for predicting clear cell renal cell carcinoma based on complement-related genes
por: Qian, Cheng, et al.
Publicado: (2023)

Establishment and validation of a polygene prognostic model for clear cell renal cell carcinoma
por: Gan, Kai, et al.
Publicado: (2022)

Author Correction: Identification of a differentiation-related prognostic nomogram based on single-cell RNA sequencing in clear cell renal cell carcinoma
por: Xia, Zhi-Nan, et al.
Publicado: (2023)

Correction to: ‘Infrastructure construction without information exchange: the trail clearing mechanism in Atta leafcutter ants’
por: Bochynek, Thomas, et al.
Publicado: (2019)

Integrated Analysis of the Roles of RNA Binding Proteins and Their Prognostic Value in Clear Cell Renal Cell Carcinoma
por: Wang, Bowen, et al.
Publicado: (2021)

Construction and validation of programmed cell death-based molecular clusters for prognostic and therapeutic significance of clear cell renal cell carcinoma
por: Tang, Yanlin, et al.
Publicado: (2023)

Correction for: Development and validation of a RNA binding protein-associated prognostic model for lung adenocarcinoma
por: Li, Wei, et al.
Publicado: (2021)

Construction and Validation of a Novel Immune Checkpoint-Related Model in Clear Cell Renal Cell Carcinoma
por: Fan, ZhiXiang, et al.
Publicado: (2022)

Correction: Identification of pVHL as a Novel Substrate for Aurora-A in Clear Cell Renal Cell Carcinoma (ccRCC)
por: Martin, Benedicte, et al.
Publicado: (2014)

Correction: Combined inhibition of PI3K and Src kinases demonstrates synergistic therapeutic efficacy in clear-cell renal carcinoma
por: Caroline, Roelants, et al.
Publicado: (2019)

Correction to: PFKFB4 is overexpressed in clear-cell renal cell carcinoma promoting pentose phosphate pathway that mediates Sunitinib resistance
por: Feng, Chenchen, et al.
Publicado: (2021)

Excavation of diagnostic biomarkers and construction of prognostic model for clear cell renal cell carcinoma based on urine proteomics
por: Yang, Yiren, et al.
Publicado: (2023)

Author Correction: The Oncogenic Role of COL23A1 in Clear Cell Renal Cell Carcinoma
por: Xu, Fujiang, et al.
Publicado: (2018)

Development and validation of a prognostic model for kidney renal clear cell carcinoma based on RNA binding protein expression
por: Xiang, Yuzhu, et al.
Publicado: (2020)

Eukaryotic Translation Initiation Factor 3b is both a Promising Prognostic Biomarker and a Potential Therapeutic Target for Patients with Clear Cell Renal Cell Carcinoma
por: Zang, Yuanwei, et al.
Publicado: (2017)

Construction of five microRNAs prognostic markers and a prognostic model for clear cell renal cell carcinoma
por: Zhou, Qi, et al.
Publicado: (2021)

Construction of a prognostic prediction model for renal clear cell carcinoma combining clinical traits
por: Weng, Yujie, et al.
Publicado: (2023)

Correction: HHLA2 and PD-L1 co-expression predicts poor prognosis in patients with clear cell renal cell carcinoma
Publicado: (2020)

Correction to: Deubiquitylase OTUD6B stabilizes the mutated pVHL and suppresses cell migration in clear cell renal cell carcinoma
por: Guo, Kai, et al.
Publicado: (2022)

Correction: Silencing circFTO inhibits malignant phenotype through modulating DUSP4 expression in clear cell renal cell carcinoma
por: Yang, Chen, et al.
Publicado: (2022)

Author Correction: Epigenetic and transcriptomic characterization reveals progression markers and essential pathways in clear cell renal cell carcinoma
por: Wu, Yige, et al.
Publicado: (2023)

Identification and validation of a hypoxia-related prognostic signature in clear cell renal cell carcinoma patients
por: Li, Zhengtian, et al.
Publicado: (2021)

Prognostic Inflammasome-Related Signature Construction in Kidney Renal Clear Cell Carcinoma Based on a Pan-Cancer Landscape
por: Zheng, Tianyu, et al.
Publicado: (2020)

External Validation of the Prognostic Value of an Immune-Associated Gene Panel for Clear Cell Renal Cell Carcinomas
por: Xie, Zhiwen, et al.
Publicado: (2021)

Correction to: CD103-positive CSC exosome promotes EMT of clear cell renal cell carcinoma: role of remote MiR-19b-3p
por: Wang, Lu, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2tpbbkvsi48kl6o0nc5vhgi5kv